Oxford researchers have developed a cancer-killing combo from gold nanoparticles harboring a dose of radiation. The compound burrows into cancer cells to attack their division mechanisms, leading to cell death.
Patients who suffer from a brutally painful genetic disease called epidermolysis bullosa, which causes blistering skin and open wounds, could benefit from a first-of-its-kind skin-based gene therapy highlighted this week in the Journal of the American Medical Association.
Cambridge, MA-based biometrics CRO Cytel opened up shop in two European locations this week: Barcelona and Paris. This brings its overall footprint across Europe, the U.S. and India to 800 staff in 10 offices.
A team at the University of California in San Francisco has brought a large-scale version of CRISPR gene editing to the fight against HIV infection, offering possibilities for both the discovery of new techniques and the ability to treat those with the virus.
The FDA released a notice Thursday to physicians saying they should stop using St. Louis-based Multidata’s radiation devices, as the company is restricted by the authorities since 2003 from designing, manufacturing, processing, and distributing them.
CRISPR gene editing is a cutting-edge tool that is gaining more and more ground as a way to treat diseases. And as shown in a new study, researchers at the Wellcome Trust Sanger Institute have identified genes that could serve as targets to treat acute myeloid leukemia.
Read any science fiction and you’ll know that robots themselves can’t feel. But in a paper published this week from the University of Pittsburgh, researchers have shown that a mind-controlled robotic arm can help paralyzed patients regain sensation in their limbs.